Clinical Trial Update: Vaccination of HIV-1 Infected Patients With Dendritic Cells in Addition to Antiretroviral Treatment - (DALIA Trial) [Phase 1]

View source ↗

Summary

The DALIA trial reports completion of a Phase 1 study evaluating vaccination with dendritic cells in HIV-1 infected patients receiving antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dendritic cell vaccine (DALIA trial)

Snippet

Sponsor: Baylor Research Institute | Conditions: HIV | Phase 1 | Status: COMPLETED